Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations
Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations
批准号:
10547803
负责人:
Qibin Qi
金额:
$60.81万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-19 至 2024-12-31
关键词:
AccelerationAcidsAdultAgeAnimal ExperimentsAnimal FeedAnimalsBacteriaBile AcidsBioinformaticsBiological MarkersBiometryBranched-Chain Amino AcidsButyratesCholineClassificationClinicalCoffeeCollaborationsCross-Sectional StudiesDataDemographic FactorsDevelopmentDiabetes MellitusDiabetes preventionDietDietary FiberEffectiveness of InterventionsEndocrine GlandsEnsureEnzymesEpidemiologyEthnic OriginEtiologyGenderGene ExpressionGene FamilyGenesGenetic TranscriptionHealthHealthcareHispanic Community Health Study/Study of LatinosHumanIncidenceInflammationInfrastructureInstitutionIntakeInterventionLevocarnitineLife StyleLinkLongitudinal StudiesMeasuresMeatMedical HistoryMedicineMetabolicMetabolic DiseasesMetabolismMetagenomicsMethodsMicrobeNon-Insulin-Dependent Diabetes MellitusNurses&apos Health StudyPathway AnalysisPathway interactionsPatternPharmaceutical PreparationsPhysical activityPhysiological ProcessesPlantsPlayPopulationPreparationPrevalencePreventionPrevention strategyProcessProspective StudiesPublic Health SchoolsQiRaceResearchResearch DesignResearch PersonnelResourcesRiskRoleSample SizeSamplingTaxonomyWeight maintenance regimenWomanbiological researchcare burdencase controlcohortcollegecostdiabetes managementdiabetes riskdietaryempowermentenergy balanceexperiencefecal metabolomefollow-upfrontierfruits and vegetablesglucose metabolismgut microbiomegut microbiotahigh riskimprovedindividual variationindividualized preventionmenmetabolomicsmetatranscriptomicsmicrobialmicrobiomemicrobiome researchmicrobiotamicrobiota metabolitesmultiple omicsmutualismnew technologynovelpersonalized approachpersonalized strategiespolyphenolprospectivesocioeconomicstrimethyloxamine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Human gut microbiota, with its massive catalytical capacity and functional potential, may act as an “endocrine
organ” and significantly contribute to metabolic health. Indeed, basic microbiological research and culture-
based human studies have elucidated multiple pathways through which human gut microbiota may modulate
the risk of developing metabolic diseases, such as type 2 diabetes (T2D). Existing human studies also
demonstrated promising evidence supporting a link between microbiome and prevalent diabetes, although few
longitudinal studies have been conducted to establish a prospective relationship between microbiome and the
risk of developing T2D. This proposal represents major research efforts to significantly accelerate the
advances in the research of microbiome and T2D risk by examining prospective relationships between gut
microbial composition, functional potential, and fecal metabolome that operate in candidate pathways and T2D
risk. We will also use network analysis and other advanced methods to interrogate the overall metagenomic,
metatranscriptomic, and metabolomic profiles in fecal samples for the identification of novel microbial features
(i.e., microbes, their functional potential, gene transcription levels, and microbiota metabolites) and pathways
that might be involved in the development of T2D. As a secondary aim, we will evaluate the interplay between
diet and microbiome on fecal metabolome and T2D risk. Furthermore, these complementary, inter-connected
study aims will be realized by an experienced investigator team consisting of researchers with expertise in
microbiome, metabolomics, biomarker research, diabetes epidemiology, biostatistics, and bioinformatics. To
facilitate better generalizability and internal validity of research findings, we will examine these novel
associations in two US cohorts with complementary ethnic and socioeconomic profiles: Nurses’ Health Study II
and Hispanic Community Health Study / Study of Latinos. Rich resources of these two cohorts, including fecal
samples, repeated assessments of diet, lifestyle, medical history, and use of medications, longitudinal follow-
up on diabetes status, and infrastructure for sample preparation/storage and computing, will empower the
investigators to accomplish the proposed aims cost-effectively. To strengthen between-institution collaboration
and ensure a successful implementation of the proposed research, Drs. Qi Sun (at Harvard T.H. Chan School
of Public Health) and Qibin Qi (at Albert Einstein College of Medicine) will share the responsibility of
overseeing the overall conduct of research through the Multiple PI mechanism. In summary, this project will
elucidate prospective associations of gut microbiome and fecal metabolome with T2D risk and facilitate
discoveries of novel microbial features relevant to T2D risk. As such, the proposed research has a great
potential to identify novel microbiota-related risk or beneficial factors for developing more targeted and
individualized strategies for the prevention and management of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations
-
批准号:10094713
-
项目类别:
-
资助金额:$66.96万
-
财政年份:2021
-
负责人:Qibin Qi
-
依托单位:
Human Gut Microbiome and Incident Diabetes Risk in U.S. Populations
-
批准号:10330542
-
项目类别:
-
资助金额:$60.81万
-
财政年份:2021
-
负责人:Qibin Qi
-
依托单位:
Metabolomics signatures underlying diet, lifestyle and gut microbiota for diabetes
-
批准号:9900778
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2019
-
负责人:Qibin Qi
-
依托单位:
Metabolomics signatures underlying diet, lifestyle and gut microbiota for diabetes
-
批准号:10381716
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2019
-
负责人:Qibin Qi
-
依托单位:
Metabolomics signatures underlying diet, lifestyle and gut microbiota for diabetes
-
批准号:10115710
-
项目类别:
-
资助金额:$55.68万
-
财政年份:2019
-
负责人:Qibin Qi
-
依托单位:
HIV Infection, Metabolites and Subclinical Atherosclerosis
-
批准号:9272929
-
项目类别:
-
资助金额:$17.23万
-
财政年份:2015
-
负责人:Qibin Qi
-
依托单位:
HIV Infection, Metabolites and Subclinical Atherosclerosis
-
批准号:9120269
-
项目类别:
-
资助金额:$15.48万
-
财政年份:2015
-
负责人:Qibin Qi
-
依托单位:
HIV Infection, Metabolites and Subclinical Atherosclerosis
-
批准号:8993153
-
项目类别:
-
资助金额:$3.45万
-
财政年份:2015
-
负责人:Qibin Qi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: